Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2021
Total Assets: $8.50B
Liabilities Breakdown FY2021
Total Liabilities: $2.67B
Asset Breakdown
Total Assets: $8.50B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $862.8M | 10.1% |
| Accounts Receivable | $582.2M | 6.8% |
| Inventory | $726.7M | 8.5% |
| Property, Plant & Equipment | $1.55B | 18.2% |
| Goodwill | $1.17B | 13.7% |
| Intangible Assets | $323.6M | 3.8% |
| Other Assets | $3.29B | 38.7% |
Liabilities Breakdown
Total Liabilities: $2.67B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $204.5M | 7.7% |
| Long-Term Debt | $595.7M | 22.3% |
| Other Liabilities | $1.87B | 70.0% |